Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
T cell metabolism drives immunity
2015
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
2011 Standout
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
2002
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
1992
Breast cancer
2016 Standout
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
1996
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Therapeutic Drug Monitoring in Oncology
1987
Adjuvant Therapy of Premenopausal and Menopausal High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B
1988
Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments
2001
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: A randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group
2006
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Essential thrombocythemia
2003
The development of androgen-independent prostate cancer
2001 Standout
The Transcriptional Landscape
2010
Osteopenia and osteoporosis in women with breast cancer
2003
Mechanisms of T Cell Development and Transformation
2011
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
The transcriptional landscape of αβ T cell differentiation
2013
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
2011
A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer
2000
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
Tamoxifen in the Treatment of Breast Cancer
1998
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
2016 StandoutNobel
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
1989
Paradoxical roles of the immune system during cancer development
2006 Standout
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Mechanisms and Functions of Inflammasomes
2014 Standout
Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma
2007
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Pathogenesis of hepatitis B virus—related hepatocellular carcinoma: Old and new paradigms
2004
Thrombotic complications in essential thrombocythemia with relatively low platelet counts
1997
Aromatase Inhibitors in the Adjuvant Treatment of Postmenopausal Women with Early Breast Cancer: Putting Safety Issues into Perspective
2007
Breast cancer metastasis: markers and models
2005 Standout
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
2007
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Genome Regulation by Long Noncoding RNAs
2012 Standout
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
2001
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
2006
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
2009
Mechanisms by which Activated Macrophages Inhibit Lymphocyte Responses
1978
Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation
2000
Immunometabolism governs dendritic cell and macrophage function
2015 Standout
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.
1980 StandoutNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Breast Cancer Treatment
2019 Standout
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102
2005
National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
2001
Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors
2017
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23
2001
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 Standout
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342
2004
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Works of Rafael Bornstein being referenced
An association between viral genes and human oncogenic alterations: The adenovirus E1A induces the Ewing tumor fusion transcript EWS–FLI1
1999
Controlled and uncontrolled thrombocytosis.Its clinical role in essential thrombocythemia
1988
Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.
1986
CSL–MAML-dependent Notch1 signaling controls T lineage–specific IL-7Rα gene expression in early human thymopoiesis and leukemia
2009
Comparison of serum concentrations of methotrexate after various routes of administration
1975
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.
1997
Clinical and Histologic Correlation of Melanoma Regression After Intralesional BCG Therapy: A Case Report2
1974